Edward Woo

- ENDRA Life Sciences announced an aggregate of **$4.9 million** in commitments for a private placement, with potential total gross proceeds of up to **$14.4 million** if all accompanying warrants are fully exercised for cash.  **[1681682_7f3a4b55b29f4ac0a3efdf9160e92548_0]** 
- The majority of the net proceeds will be allocated to establish ENDRA’s **digital asset treasury (DAT) operations** and accumulate cryptocurrency, managed by Arca Investment Management, LLC, with the balance earmarked for the TAEUS pilot validation imaging study.  **[1681682_7f3a4b55b29f4ac0a3efdf9160e92548_0]** 
- The company intends to appoint **Jeff Dorman**, Arca’s Chief Investment Officer, to its Digital Asset Advisory Board.  **[1681682_7f3a4b55b29f4ac0a3efdf9160e92548_0]** 
- The offering includes the purchase of **744,340 shares** of common stock (or prefunded warrants) and accompanying warrants to purchase up to **1,488,680 shares** of common stock, sold at a combined purchase price of **$6.57** per unit.  **[1681682_7f3a4b55b29f4ac0a3efdf9160e92548_0]**

ENDRA Life Sciences (NDRA)